Ex-Bristol Exec Named Guilford CFO
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Bristol-Myers Squibb exec William Spengler will join Guilford July 15 as exec VP and chief financial officer
You may also be interested in...
Guilford CEO Search Ends With Appointment Of Bristol Exec
Bristol VP-Strategy Dean Mitchell will join Guilford Dec. 1, replacing company co-founder Craig Smith, who is retiring. Mitchell is expected to oversee a busy period for the company, which anticipates results from up to 13 late-stage clinical trials during the next 12-18 months.
Guilford CEO Search Ends With Appointment Of Bristol Exec
Bristol VP-Strategy Dean Mitchell will join Guilford Dec. 1, replacing company co-founder Craig Smith, who is retiring. Mitchell is expected to oversee a busy period for the company, which anticipates results from up to 13 late-stage clinical trials during the next 12-18 months.
Guilford To Receive $40 Mil. To Fund Parkinson's/ED Drug Development Via Investment Deal
Newly formed corporation of investors, Symphony Neuro Development Company, will provide the funds in exchange for five-year warrants to purchase Guilford stock and exclusive rights to the drug. Guilford has an option to reacquire the drug for $75 mil.-$120 mil. between April 2005 and March 2007.